Skip to main content
Caplight Logo









OrCam

OrCam

Private
JerusalemHealthcare & Life Scienceshttps://www.orcam.com/en-us/home

Last Round

Convertible Debt

Jul 1, 2024

Est. Valuation

$1.03B

Total Funding Raised

$98.9M

Company Overview

OrCam is an assistive technology company that develops and manufactures AI-driven wearable and handheld devices to assist individuals who are blind, visually impaired, or have reading difficulties.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Computer Vision, Medical AI, Consumer Electronics

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

assistive technologywearable AIcomputer visionvisual impairmentsmart glassestext-to-speechaccessibility deviceon-device AIassistive hardwareblindness aidfacial recognitionlow vision aidassistive techAI wearablemedical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OrCam Comparables

Compare OrCam with similar companies based on industry and business-model similarity.

OrCam comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Gentex Corporation
82%
Envision
80%
EssilorLuxottica SA
77%

OrCam Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtJul 1, 2024
Series BFeb 20, 2018
Series BApr 2, 2017
Series AMar 27, 2014

Key People

Founding team and executive leadership

Elad Serfaty

CEO

Executive Team

Tal Rosenwein

CEO - Hear

Executive Team

Shmulik Turgeman

Chief Financial Officer

Executive Team

Inbal Levy-March

Chief Operating Officer, Vice President Of Sales, Marketing And Operations

Executive Team

OrCam Investors

Notable investors and investment history

OrCam investors
InvestorRounds
Clal InsuranceSeries B
Aviv Venture CapitalSeries B, Series A
Intel CapitalSeries B, Series A
Clal Insurance Enterprises Holdings Ltd.Series B
Meitav Investment HouseSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 6, 2025

    MyEye 2.0 uses artificial vision for visually impaired users.

  • Apr 2, 2017

    $41M round closed.

OrCam Filings

Explore SEC and related filing metadata, where available.

OrCam filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about OrCam's valuation, stock price, and market status.

Is OrCam a public or private company?

OrCam is a private company.

What is the current stock price of OrCam?

OrCam is a private company with no public stock price. No recent secondary market data is available.

How much is OrCam worth (valuation)?

OrCam's valuation is estimated at $1.0B based on funding round data.

Can I buy OrCam stock?

OrCam shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was OrCam's last funding round?

OrCam's most recent funding round was Convertible Debt on February 20, 2018.

Who are the main investors in OrCam?

Key investors in OrCam include Clal Insurance, Intel Capital, Clal Insurance Enterprises Holdings Ltd..

Will OrCam IPO soon?

No public IPO plans have been announced for OrCam.

How can I track OrCam secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OrCam's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersJerusalem
Employee Range170
Year Founded2010
Last FundingJul 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?